X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs JUBILANT LIFE SCIENCES - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA JUBILANT LIFE SCIENCES SANOFI INDIA/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 34.3 27.4 125.1% View Chart
P/BV x 6.5 5.6 116.1% View Chart
Dividend Yield % 1.4 0.3 427.3%  

Financials

 SANOFI INDIA   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
JUBILANT LIFE SCIENCES
Mar-14
SANOFI INDIA/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs4,560187 2,441.1%   
Low Rs4,40065 6,758.8%   
Sales per share (Unadj.) Rs1,028.5364.3 282.3%  
Earnings per share (Unadj.) Rs129.06.8 1,883.8%  
Cash flow per share (Unadj.) Rs186.024.5 759.1%  
Dividends per share (Unadj.) Rs68.003.00 2,266.7%  
Dividend yield (eoy) %1.52.4 63.7%  
Book value per share (Unadj.) Rs753.6164.9 457.0%  
Shares outstanding (eoy) m23.03159.28 14.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.40.3 1,260.1%   
Avg P/E ratio x34.718.4 188.8%  
P/CF ratio (eoy) x24.15.1 468.6%  
Price / Book Value ratio x5.90.8 778.3%  
Dividend payout %52.743.8 120.3%   
Avg Mkt Cap Rs m103,17420,061 514.3%   
No. of employees `0003.66.2 58.6%   
Total wages/salary Rs m3,59211,052 32.5%   
Avg. sales/employee Rs Th6,537.79,383.0 69.7%   
Avg. wages/employee Rs Th991.41,786.9 55.5%   
Avg. net profit/employee Rs Th819.8176.3 465.0%   
INCOME DATA
Net Sales Rs m23,68658,034 40.8%  
Other income Rs m708191 371.5%   
Total revenues Rs m24,39458,224 41.9%   
Gross profit Rs m5,2815,786 91.3%  
Depreciation Rs m1,3132,812 46.7%   
Interest Rs m153,237 0.5%   
Profit before tax Rs m4,661-72 -6,464.6%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m1,691696 242.8%   
Profit after tax Rs m2,9701,090 272.4%  
Gross profit margin %22.310.0 223.6%  
Effective tax rate %36.3-965.9 -3.8%   
Net profit margin %12.51.9 667.4%  
BALANCE SHEET DATA
Current assets Rs m15,67329,280 53.5%   
Current liabilities Rs m6,67838,912 17.2%   
Net working cap to sales %38.0-16.6 -228.8%  
Current ratio x2.30.8 311.9%  
Inventory Days Days7684 90.1%  
Debtors Days Days2251 44.0%  
Net fixed assets Rs m8,09855,712 14.5%   
Share capital Rs m230155 149.1%   
"Free" reserves Rs m17,08820,968 81.5%   
Net worth Rs m17,35626,265 66.1%   
Long term debt Rs m017,169 0.0%   
Total assets Rs m25,40088,606 28.7%  
Interest coverage x311.71.0 31,883.5%   
Debt to equity ratio x00.7 0.0%  
Sales to assets ratio x0.90.7 142.4%   
Return on assets %11.84.9 240.6%  
Return on equity %17.14.2 412.2%  
Return on capital %26.911.6 232.9%  
Exports to sales %24.537.8 64.8%   
Imports to sales %28.016.5 169.7%   
Exports (fob) Rs m5,80121,933 26.4%   
Imports (cif) Rs m6,6279,567 69.3%   
Fx inflow Rs m7,14522,004 32.5%   
Fx outflow Rs m6,84611,749 58.3%   
Net fx Rs m29910,255 2.9%   
CASH FLOW
From Operations Rs m3,2268,026 40.2%  
From Investments Rs m-1,555-1,744 89.2%  
From Financial Activity Rs m-1,818-4,447 40.9%  
Net Cashflow Rs m-1471,834 -8.0%  

Share Holding

Indian Promoters % 0.0 45.6 -  
Foreign collaborators % 60.4 3.5 1,725.7%  
Indian inst/Mut Fund % 14.4 8.7 165.5%  
FIIs % 14.6 21.2 68.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 21.1 49.8%  
Shareholders   15,184 23,815 63.8%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DR. REDDYS LAB  IPCA LABS  ALKEM LABORATORIES  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Strong US Markets; SBI, Tata Steel & Other Top Cues to Sway the Markets Today(Pre-Open)

After opening the day in green, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Feb 16, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - ALKEM LABORATORIES COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS